Sign in Pull a receipt

SNOA

Sonoma Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$278.07 sample

+3.06 (+1.11%) 1D

Market cap

$1.10T

Price as of

2026-10-29

Latest filing

8-K · 2026-09-29

Alerts

8

Price$278.07 +8.53% 3M daily closessample

278.07252.18

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: Chief Financial Officer
Oct 21INSInsider sell: Director
Oct 15INSInsider sell: EVP, Operations
Oct 08INSInsider sell: Chief Financial Officer
Oct 02INSInsider buy: EVP, Operations
Sep 29SEC8-K filed: material event
Sep 23INSInsider buy: Chief Executive Officer
Sep 15INSInsider buy: Chief Executive Officer

Sign up to see the real SNOA record →

Company facts

SEC EDGAR registration

Name: Sonoma Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: -19sample, -100 to +100
Reporting currency: USD

Who is positioning in SNOA

sample

Insiders: 19 insider transactions over 90 days, net selling, $182.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 17 funds hold $12.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$53.1B +17.0% y/y

Q4 2024Q3 2026

Inventory$32.6B +8.1% y/y

Q4 2024Q3 2026

Accounts receivable$25.1B +19.2% y/y

Q4 2024Q3 2026

Total debt$61.9B +2.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.06T +0.6% 3M
Sample peer B: $810.1B -13.3% 3M
Sample peer C: $556.2B +3.6% 3M
Sample peer D: $698.3B +16.2% 3M
Sample peer E: $952.3B -9.8% 3M